Evolent Health (EVH) Change in Accured Expenses (2015 - 2026)

Evolent Health has reported Change in Accured Expenses for 12 years, with the latest figure at -$21.0 million in Q1 2026.

• For the quarter ending Q1 2026, Change in Accured Expenses fell 11.14% year-over-year to -$21.0 million; the trailing twelve-month figure through Mar 2026 stood at $15.2 million (up 206.23% YoY), and the FY2025 full-year result was $17.3 million, up 176.15% from the prior year.
• Change in Accured Expenses for Q1 2026 stood at -$21.0 million, down from $21.7 million in the prior quarter.
• The five-year high for Change in Accured Expenses was $43.3 million in Q2 2023, with the low at -$40.3 million in Q4 2024.
• Average Change in Accured Expenses over 5 years is -$1.6 million, with a median of $2.2 million recorded in 2022.
• Peak annual rise in Change in Accured Expenses reached 260.26% in 2023, while the deepest fall reached 1514.46% in 2023.
• Tracing EVH's Change in Accured Expenses over 5 years: stood at $14.9 million in 2022, then slumped by 298.61% to -$29.6 million in 2023, then slumped by 36.28% to -$40.3 million in 2024, then surged by 153.73% to $21.7 million in 2025, then tumbled by 196.84% to -$21.0 million in 2026.
• The last three Change in Accured Expenses figures came in at -$21.0 million (Q1 2026), $21.7 million (Q4 2025), and -$8.9 million (Q3 2025), per Business Quant data.

Peer Comparison